• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有治疗应用的铁螯合剂的设计。

Design of iron chelators with therapeutic application.

机构信息

School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang 310012, P R China.

出版信息

Dalton Trans. 2012 Jun 7;41(21):6371-89. doi: 10.1039/c2dt12159j. Epub 2012 Mar 6.

DOI:10.1039/c2dt12159j
PMID:22391807
Abstract

Iron is essential for the proper functioning of all living cells, however it is toxic when present in excess. Thus, using iron chelators as therapeutic agents, namely chelation therapy, has received increasing attention. The objective of this review is to discuss the factors which should be considered when designing clinically useful iron chelators, to present the application of iron chelators in the treatment of iron overload associated with β-thalassaemia major and sickle cell anaemia, and to highlight the potential applications in the treatment of neurodegenerative disorders and microbial infection. This article reviews recent knowledge centred on these themes and indicates the growing importance of the concept of iron chelation in medicine.

摘要

铁是所有活细胞正常运作所必需的,但过量存在时会有毒性。因此,使用铁螯合剂作为治疗剂,即螯合疗法,受到了越来越多的关注。本综述的目的是讨论在设计临床上有用的铁螯合剂时应考虑的因素,介绍铁螯合剂在治疗与重型β-地中海贫血和镰状细胞贫血相关的铁过载方面的应用,并强调其在治疗神经退行性疾病和微生物感染方面的潜在应用。本文综述了这些主题的最新知识,并指出了铁螯合概念在医学中的重要性日益增加。

相似文献

1
Design of iron chelators with therapeutic application.具有治疗应用的铁螯合剂的设计。
Dalton Trans. 2012 Jun 7;41(21):6371-89. doi: 10.1039/c2dt12159j. Epub 2012 Mar 6.
2
Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.1-(2-羟乙氧基)甲基-2-烷基-3-羟基-4-吡啶酮的无环核苷铁螯合剂:潜在的口服铁螯合治疗药物。
Nucleosides Nucleotides Nucleic Acids. 2004;23(3):599-611. doi: 10.1081/NCN-120030718.
3
Advances in iron chelation: an update.铁螯合的进展:更新。
Expert Opin Ther Pat. 2011 Jun;21(6):819-56. doi: 10.1517/13543776.2011.569493. Epub 2011 Mar 30.
4
Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.毒理学的未来——铁螯合剂以及不同的作用方式和毒性:铁螯合疗法的新面貌
Chem Res Toxicol. 2007 May;20(5):715-20. doi: 10.1021/tx700039c. Epub 2007 Apr 3.
5
Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity.用于治疗铁过载疾病的铁螯合剂:结构、氧化还原活性与毒性之间的关系
Am J Hematol. 2003 Jul;73(3):200-10. doi: 10.1002/ajh.10348.
6
Chelating agents for the treatment of systemic iron overload.螯合剂治疗全身性铁过载。
Curr Med Chem. 2012;19(17):2816-27. doi: 10.2174/092986712800609724.
7
The potential application of iron chelators for the treatment of neurodegenerative diseases.铁螯合剂在治疗神经退行性疾病中的潜在应用。
Metallomics. 2011 Mar;3(3):239-49. doi: 10.1039/c0mt00087f. Epub 2011 Feb 22.
8
Drug evaluation: Deferitrin for iron overload disorders.药物评价:去铁铁蛋白用于铁过载疾病
IDrugs. 2007 Jul;10(7):480-90.
9
Therapeutic Macromolecular Iron Chelators.治疗性大分子铁螯合剂。
Curr Med Chem. 2019;26(2):323-334. doi: 10.2174/0929867325666180904104318.
10
Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.澳大利亚输血依赖型地中海贫血、镰状细胞病和其他先天性贫血患者铁过载和铁螯合治疗评估指南。
Intern Med J. 2011 Jul;41(7):516-24. doi: 10.1111/j.1445-5994.2011.02527.x.

引用本文的文献

1
Interactions Between Iron Metabolism and the Endocannabinoid System in Bacterial Infections.细菌感染中铁代谢与内源性大麻素系统之间的相互作用
Antibiotics (Basel). 2025 Jun 18;14(6):614. doi: 10.3390/antibiotics14060614.
2
Article review: Brazilin as potential anticancer agent.文章综述:巴西苏木精作为潜在抗癌剂
Front Pharmacol. 2024 Mar 7;15:1355533. doi: 10.3389/fphar.2024.1355533. eCollection 2024.
3
Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal-labeled cell transplants.
将铁螯合剂重新用于放射性金属标记细胞移植的正电子发射断层显像精确成像追踪
MedComm (2020). 2024 Jan 30;5(2):e473. doi: 10.1002/mco2.473. eCollection 2024 Feb.
4
Chelators as Antineuroblastomas Agents.螯合剂作为神经母细胞瘤的抗剂。
Physiol Res. 2023 Oct 27;72(S3):S277-S286. doi: 10.33549/physiolres.935184.
5
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.药物研发中的羟基吡喃酮衍生物:从螯合疗法到金属酶抑制剂的合理设计
RSC Med Chem. 2022 Jul 29;13(10):1127-1149. doi: 10.1039/d2md00175f. eCollection 2022 Oct 19.
6
Understanding the Potential and Risk of Bacterial Siderophores in Cancer.了解细菌铁载体在癌症中的潜力与风险。
Front Oncol. 2022 Jun 17;12:867271. doi: 10.3389/fonc.2022.867271. eCollection 2022.
7
Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present.癌症靶点核糖核苷酸还原酶的抑制剂,过去与现在
Biomolecules. 2022 Jun 10;12(6):815. doi: 10.3390/biom12060815.
8
Iron Effects on Toxin Production and Antimicrobial Susceptibilities.铁对毒素产生及抗菌药敏性的影响。
Antibiotics (Basel). 2022 Apr 19;11(5):537. doi: 10.3390/antibiotics11050537.
9
Naked Eye Chemosensor and In Vivo Chelating Activity of Iron (III) By Bromopyridine Quinoxaline (BPQ).溴吡啶喹喔啉(BPQ)对铁(III)的裸眼化学传感器及体内螯合活性
J Fluoresc. 2022 Sep;32(5):1669-1678. doi: 10.1007/s10895-022-02893-7. Epub 2022 May 27.
10
design of mimosine containing peptides as new efficient chelators of aluminum.设计含含羞草碱的肽作为新型高效铝螯合剂。
RSC Adv. 2019 Mar 7;9(14):7688-7697. doi: 10.1039/c8ra10139f. eCollection 2019 Mar 6.